Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- fatty acid biochemical MUFA monounsaturated saturated mass spectrometry LC MS LCMS LC/MS 9000339 arachidic 506-30-9 icosanoic C20:0 NSC 93983 NSC93983 n-eicosanoic arachic 10006626 lauric 143-07-7 NSC5026 5026 dodecanoic 13353 lignoceric 557-59-5 FL88 FL 88 13351 myristic 544-63-8 tetradecanoic NSC5028 5028 13940 nervonic 506-37-6 selacholeic 90260 oleic 112-80-1 cis-9-octadecenoic 10006627 palmitic 57-10-3 10009871 palmitoleic 373-49-9 n-7 palmitoleate 9-cis-hexadecenoic cis-palmitoleic palmitoleate 10011298 stearic 57-11-4 octadecanoic
- Product Overview:
This mixture contains various saturated or unsaturated fatty acids. The mixture is supplied in an amber ampule in which the headspace has been purged with argon to prevent lipid oxidation. This product has been designed for direct use in LC-MS applications. The solution may be serially diluted for preparation of calibrators and QC standards and/or used directly as a system suitability standard or tuning standard. After opening, we recommend that the mixture be transferred immediately to a 1 ml glass screw cap vial, to prevent solvent evaporation, and stored at -20°C. The mixture should be discarded after multiple freeze/thaw cycles.The saturated or unsaturated fatty acids represented in this mixture are composed of 12-24 carbons. These compounds are found naturally in plants and mammals and have important biological roles, including serving as precursors in the production of various other lipids. Some have also been used for industrial production of soaps, cosmetics, lubricants, releasing agents, and surfactants.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.